120 related articles for article (PubMed ID: 576623)
1. Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
Welsch CW; Lambrecht LK; Hassett CC
J Natl Cancer Inst; 1977 Apr; 58(4):1135-8. PubMed ID: 576623
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of early preneoplastic lesions of the mammary gland.
Welsch CW
Cancer Res; 1976 Jul; 36(7 PT 2):2621-5. PubMed ID: 1277169
[TBL] [Abstract][Full Text] [Related]
3. Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
Welsch CW
J Toxicol Environ Health Suppl; 1976; 1():161-75. PubMed ID: 1036505
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mammary tumorigenesis in GR mice with 2-bromo-alpha-ergocryptine.
Welsch CW; Goodrich-Smith M; Brown CK; Wilson M
Int J Cancer; 1979 Jul; 24(1):92-6. PubMed ID: 478693
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
[TBL] [Abstract][Full Text] [Related]
6. Prolactin and the development and progression of early neoplastic mammary gland lesions.
Welsch CW
Cancer Res; 1978 Nov; 38(11 Pt 2):4054-8. PubMed ID: 698954
[TBL] [Abstract][Full Text] [Related]
7. Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
Medina D
J Natl Cancer Inst; 1977 Apr; 58(4):1107-10. PubMed ID: 576622
[TBL] [Abstract][Full Text] [Related]
8. 17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.
Welsch CW; Adams C; Lambrecht LK; Hassett CC; Brooks CL
Br J Cancer; 1977 Mar; 35(3):322-8. PubMed ID: 576837
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion.
Welsch CW; Brown CK; Goodrich-Smith M; Van J; Denenberg B; Anderson TM; Brooks CL
J Natl Cancer Inst; 1979 Nov; 63(5):1211-4. PubMed ID: 116049
[TBL] [Abstract][Full Text] [Related]
10. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
11. The influence of prenatal or neonatal administration of 2-bromo-alpha-ergocryptine on pituitary prolactin secretion and normal and neoplastic mammary growth in adult mice.
Nagasawa H; Yanai R
J Endocrinol Invest; 1978 Jul; 1(3):273-6. PubMed ID: 583157
[TBL] [Abstract][Full Text] [Related]
12. Effects of pituitary graft and 2-bromo-alpha-ergocryptine on mammary DNA synthesis in mice in relation to mammary tumorigenesis.
Yanai R; Nagasawa H
J Natl Cancer Inst; 1976 May; 56(5):1055-6. PubMed ID: 1036504
[TBL] [Abstract][Full Text] [Related]
13. Effect of ovariectomy at different ages on development of mammary tumors in (C3H x R3)F1 mice.
Richardson FL
J Natl Cancer Inst; 1967 Aug; 39(2):347-54. PubMed ID: 18623949
[TBL] [Abstract][Full Text] [Related]
14. 2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
Welsch CW; Goodrich-Smith M; Brown CK; Mackie D; Johnson D
Oncology; 1982; 39(2):88-92. PubMed ID: 6801566
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of spontaneous mammary tumorigenesis by temporal inhibition of prolactin secretion in rats at young ages.
Nagasawa H; Morii S
Cancer Res; 1981 May; 41(5):1935-7. PubMed ID: 7214361
[TBL] [Abstract][Full Text] [Related]
16. Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
Briand P; Thorpe SM; Daehnfeldt JL
Br J Cancer; 1977 Jun; 35(6):816-21. PubMed ID: 577471
[TBL] [Abstract][Full Text] [Related]
17. A cleaved form of prolactin in the mouse pituitary gland: identification and comparison of in vitro synthesis and release in strains with high and low incidences of mammary tumors.
Sinha YN; Gilligan TA
Endocrinology; 1984 Jun; 114(6):2046-53. PubMed ID: 6723574
[TBL] [Abstract][Full Text] [Related]
18. Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine.
Sumi C; Yokoro K; Matsushima R
Cancer Res; 1983 Oct; 43(10):4781-5. PubMed ID: 6883334
[TBL] [Abstract][Full Text] [Related]
19. The foetoplacental unit and the initiation of lactation in the rat.
Nicholas KR; Hartmann PE
Aust J Biol Sci; 1981; 34(4):455-61. PubMed ID: 7305761
[TBL] [Abstract][Full Text] [Related]
20. Prolactin mediation of estrogen-induced changes in mammary tissue estrogen and progesterone receptors.
Muldoon TG
Endocrinology; 1987 Jul; 121(1):141-9. PubMed ID: 3595517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
